SEC Form 4 · accession 0001493152-18-017869
PRESSURE BIOSCIENCES INC · PBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander V Lazarev
Officer — VP of Research & Development
Period of report
Dec 19, 2018
Accepted (ET)
Dec 21, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000830656
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1,F3 | $3.40 | Dec 19, 2018 | D | 5,000 | D | — | Jul 18, 2028 | Common Stock | 5,000 | 0 | D |
| Incentive Stock OptionF1,F4,F2 | $3.40 | Dec 19, 2018 | A | 5,000 | A | — | Dec 19, 2028 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the old stock option granted on July 18, 2018 and the grant of a replacement stock option dated December 19, 2018, which includes the same exercise price of $3.40 and a new expiration date of December 19, 2028.
- F2Stock options vest 5/36th for the first month then 1/36th per month for the remaining months for a total of 36 months.
- F32015 Nonqualified Stock Option Plan.
- F42013 Equity Incentive Plan.